Oral Immune-Related Adverse Events Associated with PD-1 Inhibitor Treatment: A Case Series

Oral Immune-Related Adverse Events Associated with PD-1 Inhibitor Treatment: A Case Series

Introduction: Immune Checkpoint Inhibitor (ICI) drugs have led to a revolution in the treatment of different forms of cancer, shifting the target of action from cancer cells to the patient’s immune system, enhancing their responses against the tumor itself. On the other hand, this mechanism can lead...

Full description

Bibliographic Details
Main Authors: Daniele Pergolini, Andrea Botticelli, Roberta Fascetti, Federica Rocchetti, Alessio Cirillo, Gianluca Tenore, Gaspare Palaia, Antonella Polimeni, Umberto Romeo
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Applied Sciences
Subjects:
cancer therapy
immunotherapy
oral adverse events
oral disease
oral lesions
Online Access:https://www.mdpi.com/2076-3417/12/24/12994

Similar Items

Similar Items